CDC Announces Funding to Support Integrated Viral Hepatitis Surveillance and Prevention Programs
The Centers for Disease Control and Prevention (CDC) has announced the availability of fiscal year 2021 funds to support integrated viral hepatitis surveillance and prevention programs in states and large cities in the United States. This cooperative agreement will award approximately $21 million in the first year to support viral hepatitis surveillance and outbreak response (component 1), elimination planning and prevention services (component 2), and special projects targeted to the prevention, diagnosis, and treatment related to the infectious disease consequences of drug use (component 3). Approximately 58 recipients will be awarded under Components 1 and 2, and up to 10 recipients under Component 3. Applications are due December 1, 2020 at 11:59pm ET.
Resources from the Viral Hepatitis and Infectious Disease and the Opioid Epidemic programs support this funding opportunity. A full list of activities, including those that are optional or contingent on funding, can be found at www.grants.gov/web/grants/search-grants.html?keywords=CDC-RFA-PS21-2103.
Purpose
Priorities for this cooperative agreement are to:
- Improve surveillance for viral hepatitis in states and large cities, including outbreak detection, investigation and control;
- Facilitate state and large city viral hepatitis elimination planning;
- Increase access to hepatitis B and hepatitis C testing, and prevention and treatment services (e.g., vaccination and treatment services provided in high-impact settings, such as hospital emergency departments and syringe services programs [SSPs], and among high-burden populations).
An additional optional component funds comprehensive, outcome-focused approaches to preventing infections associated with injection drug use, reducing overdose deaths, and linking people to substance use disorder treatment.
Pre-Application Technical Assistance Activities and Resources
CDC hosted a pre-application technical assistance conference call to provide potential applicants the opportunity to ask CDC representatives specific questions related to the NOFO on September 15 (slides are available here) and will host another technical assistance conference on October 14, 2020. Potential applicants should refer to the full announcement for conference call details: Funding Opportunity Announcement CDC-RFA-PS20-2009: Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments.
Related pages and posts:
- CDC Announces Funding for Integrated Viral Hepatitis Surveillance and Prevention for Health Departments (Note: CDC previously announced the funding opportunity in March 2020, which was then cancelled.)
- Presentations from Programs That Are Integrating from the NASEM Report
